| 1.1 |
3.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.7 |
2.2 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.7 |
2.0 |
GO:0010752 |
signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) |
| 0.5 |
2.7 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 0.5 |
1.4 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.4 |
2.2 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) progesterone secretion(GO:0042701) negative regulation of hair follicle development(GO:0051799) positive regulation of ovulation(GO:0060279) |
| 0.3 |
1.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.3 |
1.1 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.2 |
0.7 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.2 |
0.7 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 |
1.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 |
0.9 |
GO:0032512 |
regulation of protein phosphatase type 2B activity(GO:0032512) positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
| 0.2 |
2.3 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 |
0.6 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.2 |
2.8 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.2 |
0.6 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.2 |
1.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.9 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
3.1 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.4 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 |
0.9 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
0.7 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.1 |
1.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.6 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.4 |
GO:2000224 |
testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.1 |
1.1 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
1.7 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.7 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.1 |
0.3 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 |
0.3 |
GO:0006059 |
hexitol metabolic process(GO:0006059) alditol biosynthetic process(GO:0019401) |
| 0.1 |
0.8 |
GO:2000809 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.1 |
0.3 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.1 |
0.2 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.1 |
1.0 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.4 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.1 |
0.4 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
1.8 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 |
2.1 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.1 |
0.4 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
0.9 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.6 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.3 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.3 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.1 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.3 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.1 |
0.3 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.4 |
GO:0061092 |
involuntary skeletal muscle contraction(GO:0003011) regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 |
0.2 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.1 |
0.5 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.1 |
0.6 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.7 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.0 |
0.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.4 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.5 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 |
0.5 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.2 |
GO:0097151 |
prolactin secretion(GO:0070459) positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.0 |
0.2 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.0 |
0.7 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.3 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
0.1 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 |
0.1 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.0 |
0.2 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.1 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 |
1.1 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
5.5 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.0 |
1.6 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
2.2 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.0 |
0.3 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.2 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.9 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.4 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.0 |
0.2 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
1.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.6 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 |
0.6 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 |
0.8 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.3 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.3 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 |
1.4 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.0 |
0.8 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.1 |
GO:0032511 |
regulation of multivesicular body size(GO:0010796) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.0 |
0.1 |
GO:0010746 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.0 |
0.3 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.1 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
0.1 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.0 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 |
0.3 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
